C17orf102 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10759
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of Human C17orf102 (NP_997337). Peptide sequence FCSRSSRGAGRGHPTPTPRVRWALAGNQPRCCAQLLSGRGGSGAQLRAGW
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
18 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for C17orf102 Antibody
Western Blot: C17orf102 Antibody [NBP3-10759]
Western Blot: C17orf102 Antibody [NBP3-10759] - Western blot analysis of C17orf102 in MCF7 Whole Cell lysates. Antibody dilution at 1.0ug/mlApplications for C17orf102 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: C17orf102
Alternate Names
chromosome 17 open reading frame 102, FLJ44815, hypothetical protein LOC400591
Gene Symbol
TMEM132E-DT
Additional C17orf102 Products
Product Specific Notices for C17orf102 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...